Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Lung Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07725939
What this trial is testing

24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

Who this might be right for
Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
UCB Biopharma SRL 402
Not applicableUnknownNCT05699512
What this trial is testing

Functional Ability, Symptoms and Quality of Life in Patients With Post Covid-19 Condition

Who this might be right for
Post Covid-19 Condition
Helsinki University Central Hospital 400
Testing effectiveness (Phase 2)UnknownNCT06492798
What this trial is testing

Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

Who this might be right for
Long COVIDPost-Acute COVID-19 Syndrome
Changhai Hospital 76
Large-scale testing (Phase 3)Study completedNCT00250679
What this trial is testing

Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary DiseaseBronchitisEmphysema
Sumitomo Pharma America, Inc. 443
Testing effectiveness (Phase 2)Study completedNCT02951312
What this trial is testing

Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sunovion Respiratory Development Inc. 12
Not applicableUnknownNCT04747366
What this trial is testing

Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity

Who this might be right for
Covid19
Charite University, Berlin, Germany 750
Testing effectiveness (Phase 2)Looking for participantsNCT07610395
What this trial is testing

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

Who this might be right for
Rhinovirus Infection
Altesa Biosciences, Inc. 180
Testing effectiveness (Phase 2)Study completedNCT04997395
What this trial is testing

Feasibility of Cannabidiol for the Treatment of Long COVID

Who this might be right for
Long COVID
Bod Australia 12
Not applicableLooking for participantsNCT06142253
What this trial is testing

Water-based Activity to Enhance Recovery in Long COVID-19

Who this might be right for
Long COVID
VA Office of Research and Development 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682402
What this trial is testing

Taurine Supplementation in Adolescents With Post-COVID Condition

Who this might be right for
Long COVIDPost COVID-19 ConditionPASC Post Acute Sequelae of COVID 19
University of Alberta 30
Not applicableEnded earlyNCT05876377
What this trial is testing

Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

Who this might be right for
SARS-CoV-2COVID-19Post-Acute COVID-19 Syndrome
Pfizer 1
Not applicableUnknownNCT00063596
What this trial is testing

Vitamin A Supplementation in Preterm Infants

Who this might be right for
Infant, Premature
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 220
Testing effectiveness (Phase 2)Study completedNCT06821087
What this trial is testing

Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19

Who this might be right for
Long COVID
University of Texas at Austin 20
Testing effectiveness (Phase 2)Study completedNCT04631016
What this trial is testing

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Chronic Bronchitis
AstraZeneca 137
Testing effectiveness (Phase 2)Ended earlyNCT04652518
What this trial is testing

LYT-100 in Post-acute COVID-19 Respiratory Disease

Who this might be right for
Covid19Post-acute COVID-19 Respiratory Disease
PureTech 185
Not applicableStudy completedNCT06437210
What this trial is testing

Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome

Who this might be right for
Post-COVID-19 SyndromeCOVID-19Dyspnea+3 more
Catalysis SL 200
Not applicableStudy completedNCT06503874
What this trial is testing

Improving Attention in Individuals With Long COVID-19

Who this might be right for
Long Covid
Shirley Ryan AbilityLab 58
Post-approval studies (Phase 4)Ended earlyNCT02034279
What this trial is testing

The INFECIR-2 Albumin Prevention Study

Who this might be right for
Advanced Chronic Liver DiseaseUrinary InfectionPneumonia+2 more
EASL - CLIF Consortium 136
Large-scale testing (Phase 3)Active Not RecruitingNCT04948203
What this trial is testing

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

Who this might be right for
Pulmonary FibrosisCOVID-19 PneumoniaLong COVID
University of Chicago 60
Not applicableStudy completedNCT00266474
What this trial is testing

Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis

Who this might be right for
Cystic FibrosisSinusitis
University of Jena 187
Next Page